 Assenagon Asset Management S.A. purchased a new position in Kindred Biosciences Inc NASDAQ:KIN during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 289,387 shares of the biopharmaceutical companys stock, valued at approximately 1,158,000. Assenagon Asset Management S.A. owned approximately 0.74 of Kindred ... 